MedTrace Logo

Tailored Interventions to Prevent Substance Abuse

NCT01482975 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4158

Last updated 2016-05-12

No results posted yet for this study

Summary

The overarching objective of this research is to prevent substance use in early adolescents through the use of innovative interactive interventions tailored to each individual's particular risk profile for using cigarettes and alcohol. The specific aims are: (1) To test the effectiveness of the computer-based profile-based tailored interventions to keep early adolescents smoke-free compared to a comparison group; (2) To test the effectiveness of the computer-based profile-based tailored interventions to keep early adolescents from using alcohol compared to a comparison group; and (3) To replicate findings that the tailored diet and physical activity interventions will be effective in reducing these two high risk behaviors as part of the comparison condition.

Conditions

  • Prevention Harmful Effects

Interventions

OTHER

Tailored computer based intervention

Best practices for TTM tailored communication with two types of feedback: normative - compared to peer and ipsative - self compared to previous assessment.

OTHER

Tailored computer intervention

Best practices for TTM tailored communication with two types of feedback: normative - compared to peer and ipsative - self compared to previous assessment

Sponsors & Collaborators

  • University of Rhode Island

    lead OTHER

Principal Investigators

  • Wayne F Velicer, PhD · Univeristy of Rhode Island

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
10 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01482975 on ClinicalTrials.gov